texas oncology more breakthroughs. more victories
  • Request an Appointment
  • Find a cancer center
  • Find a provider
  • Clinical Trials

Share:

 
 

Gurjyot Gury K. Doshi, M.D.

General Summary

Dr. Doshi is a board certified medical oncologist and hematologist who treats various cancers including breast cancer, lung and colon cancer as well as other cancers. In addition, she treats benign and malignant blood disorders.

Prior to joining Texas Oncology in 2010, Dr. Doshi was an assistant professor in the Division of Oncology at The University of Texas in the Texas Medical Center.

Education

  • Fellowship in Hematology and Oncology
    Chief Fellow, Josephine Ford Cancer Center, Henry Ford Health System, Detroit, MI
  • Internship and Residency in Internal Medicine
    Henry Ford Hospital, Detroit, MI
  • Medical Doctorate
    J.J.M. Medical College, Karnataka, India

Medical Practice

Other Information

Dr. Doshi is married and has two young children.  She enjoys dancing, playing volleyball and spending time with her kids.  She is involved with improving cancer outreach locally.

Accolades & Memberships

  • “Rising Star” Award, US Oncology Research, Annual Science Forum, 2016
  • Physician Research Champion, Gulf Coast Region, Texas Oncology
  • Medical Director, Oral Oncolytics, Texas Oncology
  • “Houston’s Top Doctors”, Houstonia Magazine, 2013, 2014
  • Chief Fellow, Josephine Ford Cancer Center, Henry Ford Hospital, Detroit, MI, 2007-2008
  • American Society of Clinical Oncology
  • American Medical Association
  • Harris County Medical Society

Community Service

Research Interest

Dr. Gury Doshi is associate chair of the genitourinary committee of US Oncology Research.

She joined the genitourinary committee program in 2012 and has quickly risen as a leader serving as US Oncology Research principal investigator for multiple studies and as a top enroller to clinical trials year after year.

Her special interest is in treatment of genitourinary tumors; prostate, kidney and bladder cancers. She conducts clinical research trials at her Memorial City office. Her research publications include a review on sequencing therapies in metastatic renal cell carcinoma, and the use of morphoproteomic analysis to determine selection of therapy in kidney cancer.

Publications

  • Sequential therapy in metastatic renal cell carcinoma.

    Journal of Kidney Cancer and VHL, 2016

  • “Early experience with Radium 223 Xofigo Therapy in Patients with Prostate Bony Metastases” Poster Presentation

    2015 World Molecular Imaging Congress. Hawaii, 2015

  • Clinical and pharmacokinetic evaluation of satraplatin.

    Expert Opinion on Drug Metabolism & Toxicology, 2012